IMI. C. McMillen

I. C. McMillen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. C. McMillen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • G. Simonetta

    Department of Physiology, University of Adelaide, Adelaide, SA 5005, Australia

    1 shared publication
  • J. S. Robinson

    Department of Obstetrics and Gynecology, University of Adelaide, Adelaide, SA 5005, Australia

    1 shared publication
  • J. Schwartz

    Departments of Physiology & Pharmacology, Obstetrics & Gynecology and the Perinatal Research Laboratory, Wake Forest University School of Medicine, Winston‐Salem, NC 27157, USA

    1 shared publication
  • Julie A. Owens

    The University of Adelaide, Discipline of Obstetrics & Gynaecology, and Robinson Research Institute, Adelaide, South Australia, Australia

    1 shared publication
  • L. J. Edwards

    Department of Physiology, University of Adelaide, Adelaide, SA 5005, Australia

    1 shared publication
  • T. G. Butler

    Department of Physiology, The University of Adelaide, Adelaide, SA 5005, Australia

    1 shared publication

Latest Publications

  • Functional heterogeneity of corticotrophs in the anterior pituitary of the sheep fetus

    by T. G. Butler, J. Schwartz, I. C. McMillen

    Parturition in the sheep is dependent on prepartum stimulation of the hypothalamo-pituitary-adrenal axis and an increase in fetal plasma cortisol concentration. We have investigated whether there are changes in the functional characteristics of the corticotrophic cells in the week before delivery or in response to an increase in circulating cortisol. Fetal sheep were infused with cortisol (2-3 mg 24 h−1 i.v.; n = 11), or saline (4.4 ml 24 h−1 i.v.; n = 10) between 109 and 116 days gestation and pituitary glands were collected from these two groups, and from a late gestational group (140-145 days gestation; n = 10) for cell culture. Cells in half the wells from each pituitary were treated with cytotoxin (Cx; a cytotoxic analogue of corticotrophin releasing hormone (CRH)) to eliminate CRH target cells before exposure to ovine (o)CRH (10−8 M), arginine vasopressin (AVP; 10−7 M) or oCRH + AVP. We have demonstrated that around 70% of adrenocorticotrophic hormone (ACTH) in the fetal anterior pituitary is stored within corticotrophs which are CRH responsive. Cortisol acts to inhibit ACTH synthesis in corticotrophic cells which are CRH responsive, whereas AVP-responsive cells in the fetal pituitary are relatively resistant to cortisol. We propose that the stimulatory influence of the fetal hypothalamus must counteract the negative feedback effect of cortisol in the CRH-responsive cells to stimulate the increase in pituitary ACTH output which occurs before delivery.


  • Open Access

    Restriction of placental and fetal growth in sheep alters fetal blood pressure responses to angiotensin II and captopril

    by L. J. Edwards, G. Simonetta, J. A. Owens, J. S. Robinson, I. C. McMillen

    1 We have measured arterial blood pressure between 115 and 145 days gestation in normally grown fetal sheep (control group; n= 16) and in fetal sheep in which growth was restricted by experimental restriction of placental growth and development (PR group; n= 13). There was no significant difference in the mean gestational arterial blood pressure between the PR (42.7 ± 2.6 mmHg) and control groups (37.7 ± 2.3 mmHg). Mean arterial blood pressure and arterial P   O   2 were significantly correlated in control animals (r= 0.53, P < 0.05, n= 16), but not in the PR group. 2 There were no changes in mean arterial blood pressure in either the PR or control groups in response to captopril (7.5 μg captopril min−1; PR group n= 7, control group n= 6) between 115 and 125 days gestation. After 135 days gestation, there was a significant decrease (P < 0.05) in the fetal arterial blood pressure in the PR group but not in the control group during the captopril infusion (15 μg captopril min−1; PR group n= 7, control group n= 6). 3 There was a significant effect (F= 14.75; P < 0.001) of increasing doses of angiotensin II on fetal diastolic blood pressure in the PR and control groups. The effects of angiotensin II were different (F= 8.67; P < 0.05) in the PR and control groups at both gestational age ranges. 4 These data indicate that arterial blood pressure may be maintained by different mechanisms in growth restricted fetuses and normally grown counterparts and suggests a role for the fetal renin-angiotensin system in the maintenance of blood pressure in growth restricted fetuses.